Quantcast

Latest UCLA's Jonsson Comprehensive Cancer Center Stories

2010-04-21 05:00:00

CHICAGO, April 21 /PRNewswire/ -- A clinical study underway at Rex Cancer Center of Wakefield will evaluate the use of telemonitoring in managing administration of Gleevec, a drug developed and manufactured by Novartis to treat chronic myeloid leukemia. The study will assess the use of a cellphone-based, personalized drug management system called eMedonline to help manage patients' compliance with Gleevec, and help identify and manage side effects. Many new cancer treatments are delivered...

a9ae9ef82642d17bde6bfc0a3b3c5a7f1
2010-03-22 06:45:00

Researchers unveil scientific results from siRNA Phase I clinical trial in cancer patients A California Institute of Technology (Caltech)-led team of researchers and clinicians has published the first proof that a targeted nanoparticle"”used as an experimental therapeutic and injected directly into a patient's bloodstream"”can traffic into tumors, deliver double-stranded small interfering RNAs (siRNAs), and turn off an important cancer gene using a mechanism known as RNA...

2010-03-16 13:15:09

New results from a major initiative on the quality of cancer care in the United States show that patients with a common type of colon cancer -- especially older patients -- often are not treated as aggressively with chemotherapy as research shows is necessary to improve survival. Led by researchers from the RAND Corporation and UCLA, the study is among the first to track how findings from specialty research trials are applied in diverse practices in the community where a wider variety of...

2010-03-03 13:18:10

A combination of two targeted therapies already shown to be effective in breast cancer packs an effective one-two punch against a subset of gastric cancers that have a specific genetic mutation, a study at UCLA's Jonsson Comprehensive Cancer Center has found. The drugs Herceptin and Tykerb when given together proved to significantly inhibit tumor growth in gastric cancers that had amplified levels of HER2, a mutation that results in an aggressive form of the disease, causing the cancers to...

65e5f629929fa527dba51ed59b45f80c1
2010-02-24 15:59:52

Researchers develop novel strategy to probe 'genetic haystack' In ongoing work to identify how genes interact with social environments to impact human health, UCLA researchers have discovered what they describe as a biochemical link between misery and death. In addition, they found a specific genetic variation in some individuals that seems to disconnect that link, rendering them more biologically resilient in the face of adversity. Perhaps most important to science in the long term,...

2010-02-16 16:36:50

Finding could lead to earlier diagnosis and treatment of devastating disease Physicians and scientists agree: If we cannot entirely prevent cancer, the next best thing is to find it earlier to augment the chances of a successful fight. The good news is that there may soon be a new weapon in the battle against the so-called "worst" cancer "” cancer of the pancreas. A multidisciplinary group of investigators from the UCLA School of Dentistry, the David Geffen School of Medicine at...

2010-02-11 14:32:52

Specific chemical modifications to proteins called histones, which are found in the nucleus of cells and act as spools around which DNA is wound, can be used to predict prognosis and response to treatment in subsets patients with pancreatic cancer, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center has found. High levels of two specific histone modifications in tumor cells of patients who underwent surgical resection of their pancreatic cancer predicted those patients more...

2010-01-29 14:21:17

Study may result in new and more effective therapies Researchers at UCLA's Jonsson Comprehensive Cancer Center have performed the first complete genomic sequencing of a brain cancer cell line, a discovery that may lead to personalized treatments based on the unique biological signature of an individual's cancer and a finding that may unveil new molecular targets for which more effective and less toxic drugs can be developed. The study also may lead to new and better ways to monitor for brain...

2009-12-02 11:24:48

UT Southwestern Medical Center researchers have found that a naturally occurring protein "” transforming growth factor beta1 (TGF-ß1) "” which normally suppresses the growth of cancer cells, causes a rebound effect after a prolonged exposure. Cancer cells go into overdrive and become even more aggressive and likely to spread, the researchers report. The mechanism for this reversal is unknown, but UT Southwestern researchers and their colleagues in...

2009-11-19 10:15:00

Society's Medal of Honor to be Awarded on November 19 LOS ANGELES, Nov. 19 /PRNewswire-USNewswire/ -- The American Cancer Society -- the nation's leading voluntary health organization and largest non-governmental investor in cancer research -- will present its highest honor, the Medal of Honor, to four Americans who have made outstanding contributions to the fight for a world with less cancer and more birthdays. This year's winners, who will receive their awards at a ceremony during the...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related